Cite
HARVARD Citation
Collins, C. et al. (2014). FRI0374 Outcomes in Systemic Lupus Erythematosus Patients with High Disease Activity Treated with Belimumab: 18 Month Results from the US Observe Study. Annals of the rheumatic diseases. p. 522. [Online].